Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers

被引:38
|
作者
Ruan, Miao [1 ,2 ]
Tian, Tian [1 ,2 ]
Rao, Jia [1 ,2 ]
Xu, Xiaoli [1 ,2 ]
Yu, Baohua [1 ,2 ]
Yang, Wentao [1 ,2 ]
Shui, Ruohong [1 ,2 ]
机构
[1] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
关键词
Tumor-infiltrating lymphocytes; Breast cancer; Triple-negative; Pathological complete response; Predictive factor; PROGNOSTIC VALUE; CHEMOTHERAPY; SURVIVAL; RECOMMENDATIONS; THERAPY; TILS;
D O I
10.1186/s13000-018-0743-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Triple-negative breast cancers (TNBCs) are a group of heterogeneous diseases with various morphology, prognosis, and treatment response. Therefore, it is important to identify valuable biomarkers to predict the therapeutic response and prognosis for TNBCs. Tumor-infiltrating lymphocytes (TILs) may have predictive value to pathological complete response (pCR) in neoadjuvant treated TNBCs. However, absence of standardized methodologies for TILs measurement has limited its evaluation and application in practice. In 2014, the International TILs Working Group formulated the recommendations of pathologic evaluation for TILs in breast cancers. Methods: To evaluate the predictive value of TILs scored by methods recommended by International TILs Working Group 2014, we performed a retrospective study of TILs in 166 core needle biopsy specimens of primary invasive TNBCs with neoadjuvant chemotherapy (NAC) in a Chinese population. Intratumoral TILs (TILs) and stromal TILs (sTILs) were scored respectively. The associations between TILs and pCR were analyzed. Results: Both sTILs (p = 0.0001) and iTILs (P = 0.001) were associated with pCR in univariate logistic regression analysis. Multivariate logistic regression analysis indicated that both sTILs (P = 0.006) and TILs (P= 0.04) were independent predictors for pCR. Receiver operating characteristics (ROC) curve analysis was used to identify the optimal thresholds of TILs. TNBCs with more than 20% sTILs (P = 0.001) or with more than 10% iTILs (P = 0.003) were associated with higher pCR rates in univariate analysis. Multivariate analysis showed that a 20% threshold of sTILs (P= 0.005) was an independent predictive factor for pCR. Conclusions: Our study indicated that Its scored by recommendations of International Its Working Group 2014 in pre-NAC core needle biopsy specimens was significantly correlated with pCR in TNBCs, higher TILs scores predicting higher pCR rate. Both sTILs and iTILs were independent predictors for pCR in TNBCs. A 20% threshold for sILs may be feasible to predict pCR to NAC in TNBCs.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers
    Ruan, Miao
    Tian, Tian
    Rao, Jia
    Xu, Xiaoli
    Yu, Bao-Hua
    Yang, Wentao
    Shui, Ruohong
    MODERN PATHOLOGY, 2018, 31 : 102 - 102
  • [2] Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
    Miao Ruan
    Tian Tian
    Jia Rao
    Xiaoli Xu
    Baohua Yu
    Wentao Yang
    Ruohong Shui
    Diagnostic Pathology, 13
  • [3] Predictive Value of Tumor-Infiltrating Lymphocytes to Pathological Complete Response in Neoadjuvant Treated Triple-Negative Breast Cancers
    Ruan, Miao
    Tian, Tian
    Rao, Jia
    Xu, Xiaoli
    Yu, Bao-Hua
    Yang, Wentao
    Shui, Ruohong
    LABORATORY INVESTIGATION, 2018, 98 : 102 - 102
  • [4] Predictive value of tumour infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancer
    Babbar, P. N.
    ANNALS OF ONCOLOGY, 2020, 31 : S1239 - S1239
  • [5] Prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancers (TNBC) treated with neoadjuvant chemotherapy (NAC)
    Herrero-Vicent, C.
    Guerrero, A.
    Gavila, J.
    Gozalbo, F.
    Blanch, S.
    Hernandez, A.
    Sandiego, S.
    Calatrava, A.
    Guillem, V.
    Ruiz, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
    Tian, Tian
    Ruan, Miao
    Yang, Wentao
    Shui, Ruohong
    ONCOTARGET, 2016, 7 (28) : 44395 - 44405
  • [7] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
  • [8] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, Makiko
    Tsuda, Hitoshi
    Shimizu, Chikako
    Yamamoto, Sohei
    Shibata, Tatsuhiro
    Yamamoto, Harukaze
    Hirata, Taizo
    Yonemori, Kan
    Ando, Masashi
    Tamura, Kenji
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 793 - 805
  • [9] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Si-Lin K.
    Kiley L.
    Kamis S.
    Iqbal J.
    Dent R.
    Sim Y.Y.
    Current Breast Cancer Reports, 2015, 7 (4) : 232 - 241
  • [10] Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis
    Sun, Hai-Kuan
    Jiang, Wen-Long
    Zhang, Shi-Lei
    Xu, Peng-Cheng
    Wei, Li-Min
    Liu, Jiang-Bo
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (07):